ArticleACR open rheumatology2019

Patient Perspectives on Switching from Infliximab to Infliximab-dyyb in Patients with Rheumatologic Diseases in the United States.

Jason Chau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.